T. Rowe Price Investment Management, Inc. Atri Cure, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.6MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$186 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$184 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$158 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$113 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$111 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.85B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...